One great aspect of the research industry is being on the cutting-edge of new, innovative technologies. Looking back at the history of medical devices, it’s amazing how far technology has brought us. New devices are incorporating more complex technologies then ever before. These medical advances are to help treat patients; however, does the increase in innovation also mean an increase in safety risks?

A recent DeviceTalk blog on MD+DI caught my attention. The article’s title, “What’s in a Medical Device’s Name? For Patients, a Lot” speaks to the fact that for some patients a lifetime is spent with their medical device. This is especially true for those with chronic conditions, like Type I diabetes.

It’s the age old debate… Is the US regulatory system or the EU regulatory system better for the medical device industry? Recently in PLoS Medicine Journal the results of a systematic review was published that evaluated the two systems.